News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,104 Results
Type
Article (69538)
Company Profile (165)
Press Release (695401)
Section
Business (211808)
Career Advice (3362)
Deals (37541)
Drug Delivery (126)
Drug Development (87045)
Employer Resources (180)
FDA (17520)
Job Trends (16172)
News (365946)
Policy (37062)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2917)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (89)
Alliances (53028)
ALS (94)
Alzheimer's disease (1475)
Antibody-drug conjugate (ADC) (138)
Approvals (17486)
Artificial intelligence (280)
Autoimmune disease (22)
Automation (14)
Bankruptcy (372)
Best Places to Work (12248)
BIOSECURE Act (21)
Biosimilars (114)
Biotechnology (103)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (272)
Cancer (2168)
Cardiovascular disease (188)
Career advice (2850)
Career pathing (33)
CAR-T (159)
Cell therapy (451)
Cervical cancer (21)
Clinical research (70134)
Collaboration (839)
Compensation (491)
Complete response letters (29)
COVID-19 (2836)
CRISPR (43)
C-suite (233)
Cystic fibrosis (105)
Data (2036)
Decentralized trials (2)
Denatured (38)
Depression (50)
Diabetes (273)
Diagnostics (6732)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (132)
Drug pricing (122)
Drug shortages (32)
Duchenne muscular dystrophy (94)
Earnings (82897)
Editorial (40)
Employer branding (22)
Employer resources (156)
Events (117969)
Executive appointments (693)
FDA (18706)
Featured Employer (46)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (741)
Gene editing (111)
Generative AI (30)
Gene therapy (325)
GLP-1 (815)
Government (5012)
Grass and pollen (5)
Guidances (49)
Healthcare (20344)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (130)
Indications (27)
Infectious disease (2987)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (91)
Interviews (641)
IPO (17233)
IRA (51)
Job creations (4365)
Job search strategy (2364)
Kidney cancer (10)
Labor market (33)
Layoffs (538)
Leadership (21)
Legal (9174)
Liver cancer (76)
Lung cancer (319)
Lymphoma (139)
Machine learning (4)
Management (62)
Manufacturing (304)
MASH (69)
Medical device (14144)
Medtech (14149)
Mergers & acquisitions (20810)
Metabolic disorders (730)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (105)
Neuropsychiatric disorders (31)
Neuroscience (2030)
NextGen: Class of 2025 (7208)
Non-profit (4973)
Northern California (2505)
Now hiring (17)
Obesity (399)
Opinion (267)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (78)
Parkinson's disease (153)
Partnered (21)
Patents (220)
Patient recruitment (101)
Peanut (51)
People (62742)
Pharmaceutical (46)
Pharmacy benefit managers (21)
Phase I (21614)
Phase II (30571)
Phase III (23127)
Pipeline (1114)
Podcasts (110)
Policy (141)
Postmarket research (3221)
Preclinical (9470)
Press Release (71)
Prostate cancer (100)
Psychedelics (38)
Radiopharmaceuticals (265)
Rare diseases (406)
Real estate (6736)
Recruiting (71)
Regulatory (25044)
Reports (44)
Research institute (2586)
Resumes & cover letters (519)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (76)
Series A (133)
Series B (83)
Service/supplier (14)
Sickle cell disease (56)
Southern California (2170)
Special edition (18)
Spinal muscular atrophy (163)
Sponsored (33)
Startups (3783)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (14)
The Weekly (70)
United States (22090)
Vaccines (767)
Venture capitalists (39)
Webinars (12)
Weight loss (289)
Women's health (36)
Worklife (19)
Date
Today (121)
Last 7 days (688)
Last 30 days (2656)
Last 365 days (34968)
2025 (8986)
2024 (36775)
2023 (41668)
2022 (52929)
2021 (57694)
2020 (56553)
2019 (50046)
2018 (38061)
2017 (35470)
2016 (35799)
2015 (41373)
2014 (35528)
2013 (31394)
2012 (33196)
2011 (33228)
2010 (32288)
Location
Africa (1068)
Alabama (56)
Alaska (7)
Arizona (224)
Arkansas (14)
Asia (44908)
Australia (7787)
California (5678)
Canada (1887)
China (503)
Colorado (255)
Connecticut (277)
Delaware (132)
Europe (103763)
Florida (853)
Georgia (208)
Hawaii (1)
Idaho (60)
Illinois (557)
India (27)
Indiana (303)
Iowa (9)
Japan (146)
Kansas (104)
Kentucky (25)
Louisiana (11)
Maine (70)
Maryland (889)
Massachusetts (4319)
Michigan (228)
Minnesota (389)
Mississippi (2)
Missouri (86)
Montana (30)
Nebraska (24)
Nevada (57)
New Hampshire (69)
New Jersey (1663)
New Mexico (31)
New York (1646)
North Carolina (1024)
North Dakota (7)
Northern California (2505)
Ohio (201)
Oklahoma (15)
Oregon (36)
Pennsylvania (1270)
Puerto Rico (9)
Rhode Island (27)
South America (1472)
South Carolina (19)
South Dakota (1)
Southern California (2170)
Tennessee (97)
Texas (844)
Utah (172)
Virginia (138)
Washington D.C. (63)
Washington State (524)
West Virginia (3)
Wisconsin (53)
765,104 Results for "crohn s and colitis foundation of america ccfa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn’s & Colitis Foundation Congress
January 16, 2025
·
6 min read
BioMidwest
Geneoscopy to Present Research on Inflammatory Bowel Disease at Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference
Geneoscopy, Inc. will present research at the Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference in Cambridge, Mass., April 9-10.
April 3, 2024
·
2 min read
Business
Azenta Announces Collaboration with the Crohn’s & Colitis Foundation to Support its Crohn’s Disease and Ulcerative Colitis Clinical Research
Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Crohn’s & Colitis Foundation (the “Foundation”) as its sample management services provider for two of its large-scale prospective research cohorts, CAPTURE IBD and IBD SIRQC, which investigate pediatric and surgical care for Crohn’s disease and ulcerative colitis.
June 4, 2024
·
4 min read
Inflammatory bowel disease
Lilly and J&J Face Off in Crohn’s Disease With Phase III Readouts at ACG 2024
Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease following approvals for ulcerative colitis. GlobalData projects total sales for Tremfya to reach $7.8 billion globally by 2029.
October 29, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress
February 4, 2025
·
1 min read
Press Releases
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
February 27, 2025
·
7 min read
Press Releases
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
February 24, 2025
·
13 min read
Press Releases
Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress
January 29, 2025
·
1 min read
Press Releases
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
January 23, 2025
·
4 min read
Press Releases
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
February 14, 2025
·
2 min read
1 of 76,511
Next
